About Public Health Vaccines

The PHV Team (with its Strategic Alliance Partners) brings to bear significant technical, programmatic, and corporate biopharma product development experience and expertise. It includes many of the same individuals that successfully advanced the development of the rVSV Zaire Ebola vaccine under two federally funded contracts.

This team has an in depth understanding of the rVSV technology platform, demonstrated expertise advancing other filovirus and emerging infectious disease vaccines, and in general, a proven track record of successfully developing new vaccine candidates to late-stage development and registration.